Publication of 2 new articles involving SOLADIS

Two of the projects our team are working for our pharma clients have been published !

With those 2 articles, Soladis records its 95th and 96th publications.

« Basophils from allergic patients are neither hyper-responsive to activation signals nor hypo-responsive to inhibition signals. », a study published in the Journal of Allergy and Clinical Immunology.

and

« Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines. », published in The Journal of Infectious Diseases.

group.soladis-blanc

Soladis - France (siège)
6-8 rue Bellecombe
69006 LYON - FRANCE
Tél: +33(0)4.72.83.86.70

Soladis GmbH - Suisse
Lange Gasse 15
CH-4052 Basel
Phone: +41(0)58.258.15.80

Soladis Inc. - USA
185 Alewife Brook Pkwy, Unit 210
Cambridge, MA 02138-1100
Phone: (+1)347.417.4008

Soladis Canada
545 King Street West, Suite 309,
TORONTO, ON M5V 1M1
Phone: (+1)437.970.6462

      NOUS CONTACTER

      MENU

      MENU

      Suscribe to our newsletter